Ankara University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey
J Clin Res Pediatr Endocrinol. 2020 Sep 2;12(3):241-247. doi: 10.4274/jcrpe.galenos.2019.2019.0099. Epub 2019 Dec 17.
Standard short adrenocorticotropic hormone (ACTH) stimulation test (SST) has traditionally been used for assessing adrenal gland fuction by intravenous (iv) application. However the iv form is not readily available in all countries, including Turkey. The aim of this study was to evaluate the effectiveness of the intramuscular (im) SST.
Patients underwent im SST with suspected adrenal insufficiency (AI) and hyperandrogenism. The SSTs were done with 250 mcg ACTH (Synacthen Depot ampul, concentration 1 mg/mL). The cases were divided into two groups: suspected AI (group 1 n=87); and hyperandrogenism group (group 2 n=124). Definite AI was defined as peak cortisol <18 μg/dL, suspected AI as a peak cortisol of 18-21 μg/dL and normal result was defined as a peak cortisol ≥22 μg/dL.
The mean age of the patients was 11.7±5.2 years. In 164 patients (78%) all of the peak cortisol tests were normal (≥22 mcg/dL). The rates were 64% and 88% in group 1 and 2, respectively. Only 8.5% (n=18) of all cases had an inadequate peak cortisol response of <18 mcg/dL. On follow up, 15 patients whose peak cortisol was <18 mcg/dL needed cortisol therapy. Of all cases 3.3% (n=8) had 17-OHP ≥10 ng/dL. Clinical findings suggestive of non-classical congenital adrenal hyperplasia and/or mutation were found in six of these cases (75%). No local and systemic side effects or allergic reactions were observed in any patient.
IM ACTH SST is a safe, effective and reliable test in children with suspected AI. There were no local or systemic side effects, supporting the reliability of the im ACTH test.
传统的标准短促肾上腺皮质激素(ACTH)刺激试验(SST)通过静脉(iv)给药用于评估肾上腺功能。然而,包括土耳其在内的许多国家都无法获得 iv 形式的 SST。本研究旨在评估肌肉内(im)SST 的有效性。
怀疑肾上腺功能不全(AI)和高雄激素血症的患者接受 im SST。SST 采用 250 mcg ACTH(Synacthen Depot 安瓿,浓度 1mg/mL)进行。将病例分为两组:疑似 AI 组(1 组,n=87);和高雄激素血症组(2 组,n=124)。明确的 AI 定义为峰值皮质醇<18μg/dL,疑似 AI 定义为峰值皮质醇为 18-21μg/dL,正常结果定义为峰值皮质醇≥22μg/dL。
患者的平均年龄为 11.7±5.2 岁。在 164 例患者(78%)中,所有峰值皮质醇检测均正常(≥22 mcg/dL)。1 组和 2 组的比例分别为 64%和 88%。仅有 8.5%(n=18)的病例出现<18 mcg/dL 的峰值皮质醇反应不足。在随访中,15 例峰值皮质醇<18 mcg/dL 的患者需要皮质醇治疗。所有病例中,3.3%(n=8)的 17-羟孕酮(17-OHP)≥10ng/dL。在这些病例中,有 6 例(75%)发现存在非经典先天性肾上腺增生症和/或突变的临床特征。在任何患者中均未观察到局部和全身副作用或过敏反应。
IM ACTH SST 是一种安全、有效且可靠的儿童疑似 AI 检测方法。无局部或全身副作用,支持 im ACTH 检测的可靠性。